IP Library Granted Patent US 8,039,025
Granted Patent B1
US 8,039,025 · App. 13/157,249 · Granted Oct 18, 2011

Methods and dosage forms for the treatment of human cancers

Assignee: Life Plus, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,025
App. No.
13/157,249
Granted
Oct 18, 2011
Kind
B1
Abstract

Methods for the treatment of human cancers, daily dosage forms for cancer patients, and methods of formulating the dosage forms are provided wherein the daily dosage form contains from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. Preferably, the dosage forms are formulated by first creating an aqueous decoction of Arum palaestinum Boiss, followed by fortification of the decoction with additional quantities of β-sitosterol, isovanillin, and linolenic acid.

Claims (15)

1. A human cancer treatment comprising administering to a cancer patient a daily dosage form containing from about 1,000-4,000 mg of each of β-sitosterol, isovanillin, and linolenic acid, said treatment including the step of administering said dosage form on a daily basis to a cancer patient, wherein said daily dosage form is prepared by the steps of:

creating an aqueous decoction of Arum palaestinum Boiss; and

fortifying said decoction by adding thereto amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction such that total quantities of β-sitosterol, isovanillin, and linolenic acid are each from about 1,000-4,000 mg.

2. The treatment of claim 1 , wherein the fortified aqueous decoction is lypholized and provided in the form of a capsule.

3. A method of preparing a daily dosage form for the treatment of human cancers comprising the steps of:

creating an aqueous decoction of Arum palaestinum Boiss; and

fortifying said decoction by adding thereto amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction such that total quantities of β-sitosterol, isovanillin, and linolenic acid are each from about 1,000-4,000 mg.

4. The method of claim 3 , said dosage form containing from about 2,500-3,500 mg of each of β-sitosterol, isovanillin, and linolenic acid.

5. The method of claim 3 , the decoction-creating step comprising the steps of:

comminuting plant parts of Arum palaestinum Boiss;

placing said comminuted plant parts in water to form a mixture;

boiling the mixture for a period of time; and

allowing the mixture to cool.

6. The method of claim 5 , said plant parts comprising from about 12-18 grams of leaves and from about 12-18 grams of root, said mixture comprising said leaves and root in about one gallon of water, including the step of boiling said mixture for a period of from about 10-15 minutes.

7. The method of claim 3 , including the step of lyophilizing said fortified decoction.

Assignments (4)
MERGER Recorded Aug 30, 2018
From: IONS PHARMACEUTICAL S.A R.L.
To: ANKH LIFE SCIENCES LIMITED
Reel/Frame 046760/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2016
From: GENZADA PHARMACEUTICALS LLC
To: IONS PHARMACEUTICAL S.À R.L.
Reel/Frame 039346/0208 →
CHANGE OF NAME Recorded Jun 28, 2016
From: LIFE PLUS, LLC
To: GENZADA PHARMACEUTICALS LLC
Reel/Frame 039183/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2011
From: ZAID, GENE H.; BURGOYNE, THOMAS W.; WOLF, BETH ANN
To: LIFE PLUS, LLC
Reel/Frame 026420/0351 →
Continuity (1)
Continuation 12905847 · Oct 15, 2010